Word: cdc
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...H1N1/09 flu appears to be mild overall and treatable with existing antiviral therapies. But given that the virus continues to cause some serious cases of illness and death, the U.S. Centers for Disease Control and Prevention (CDC) isn't taking any chances. On Wednesday, July 29, the agency called an urgent meeting of its Advisory Committee on Immunization Practices, which decides who gets vaccinated against which diseases and when. The committee was asked to generate guidelines for H1N1/09 vaccination, if and when the agency determines that such immunizations become necessary, in addition to those for seasonal flu. (Read "The Year...
Notably absent from the target list are the elderly, those over age 65, who are generally considered a high-risk group when it comes to seasonal influenza. Based on the populations who were hardest hit by H1N1/09 last spring, first in Mexico and then across other continents, CDC experts believe that the elderly will not be as vulnerable to H1N1/09 in the fall as younger adults might be. In fact, health officials have relegated the elderly to the back of the line for H1N1/09 vaccinations - after the five target groups have received their shots, the next eligible group would...
Sources: Number of uninsured: CDC, 2006 data; poll data: ABC News/Washington Post, June 18-21, 2009; potential enrollees to a public plan: the Lewin Group, April 2009; insurance-company market share: National Association of Insurance Commissioners
...deadliness of a newly emerging infection in real time. "The declaration of a pandemic does not suggest that there has been any change in the behavior of the virus," said Dr. Thomas Frieden in his first press conference as director of the Centers for Disease Control and Prevention (CDC). "It only means that it is spreading in more parts of the world." (See pictures of thermal scanners hunting for swine...
...Here in the U.S., the Phase 6 declaration isn't going to change what we do day to day," said Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases. The Department of Health and Human Services has allocated $1 billion to the development, testing and production of an H1N1 vaccine, and five different companies, including GlaxoSmithKline and Sanofi-Aventis, currently have the seed virus from CDC that will form the core of the immunization. But a vaccine won't be ready until September at the earliest, and even then, it won't be clear...